Principal Investigator
Byron Lam
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240945
Clinical Trial Summary
A Phase 1/2a study of subretinal administration of OpCT-001
photoreceptor precursor cells derived from iPSCs in patients with
primary photoreceptor disease
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other